Impact of Data Imputation Methodology on Pain Assessment over 24 Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated with Postherpetic Neuralgia | Zendy

Anne Calkins | Zendy; Jeff Gudin | Zendy; Barry E. Gidal | Zendy; Mark Jaros | Zendy; Richard Kim | Zendy; Gwendoline Shang | Zendy

Open Access

Impact of Data Imputation Methodology on Pain Assessment over 24 Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated with Postherpetic Neuralgia

Author(s) -

Anne Calkins,

Jeff Gudin,

Barry E. Gidal,

Mark Jaros,

Richard Kim,

Gwendoline Shang

Publication year - 2016

Publication title -

pain medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.893

H-Index - 97

eISSN - 1526-4637

pISSN - 1526-2375

DOI - 10.1093/pm/pnv072

Subject(s) - postherpetic neuralgia , gabapentin , medicine , placebo , neuropathic pain , anesthesia , clinical endpoint , population , randomized controlled trial , alternative medicine , environmental health , pathology

To assess the impact of gabapentin enacarbil on primary and secondary pain endpoints using three data imputation methodologies in a randomized phase II study of adult patients with postherpetic neuralgia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research